1Smart MEC Healthcare R&D Center, CHA Future Medicine Research Institute, CHA Bundang Medical Center, CHA University, Seongnam, Korea
2Department of Obstetrics and Gynecology, MizMedi Hospital, Seoul, Korea
3Department of Obstetrics and Gynecology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Korea
4Department of Biomedical Informatics, Graduate School of Medicine, CHA University, Seongnam, Korea
5Institute for Biomedical Informatics, Graduate School of Medicine, CHA University, Seongnam, Korea
6Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University School of Medicine, Seoul, Korea
7Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
8Department of Obstetrics and Gynecology, Ajou University School of Medicine, Suwon, Korea
9Department of Digital Health, Samsung Advanced Institute for Health Sciences & Technology, Sungkyunkwan University, Seoul, Korea
Copyright © 2025 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST
No potential conflict of interest relevant to this article was reported.
AUTHOR CONTRIBUTIONS
Conception or design: M.Y.K., H.M.R.
Acquisition, analysis, or interpretation of data: J.H.L., M.H.K., H.J.H., Y.J.H., J.H.C., D.W.K., M.Y.K., H.M.R.
Drafting the work or revising: J.H.L., M.H.K.
Final approval of the manuscript: all authors.
FUNDING
This work was supported by grants from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI21C1779 and RS2022-KH129953).
ACKNOWLEDGMENTS
We express our sincere gratitude to the Division of Maternal-Fetal Medicine in Cheil General Hospital and CHA Hospital who were involved in the KPOS research (the Korea National Institute of Health research project: 2015-E6302-00).
Characteristic | GDM (n=231) | Normal (n=3,226) | P value |
---|---|---|---|
Maternal age, yr | |||
Maternal age <35 | 114 (49.4) | 2,078 (64.4) | <0.001 |
Maternal age ≥35 | 117 (50.6) | 1,148 (35.6) | |
Pre-pregnancy BMI, kg/m2 | |||
BMI <23 | 130 (563) | 2,609 (80.9) | <0.001 |
23≤ BMI <25 | 36 (15.6) | 325 (10.1) | |
BMI ≥25 | 65 (28.1) | 292 (9.1) | |
Educational status | |||
≤High school | 29 (12.6) | 255 (7.9) | 0.033 |
College | 169 (73.2) | 2,418 (75.0) | |
Graduate school | 33 (14.3) | 553 (17.1) | |
Household income, Korean won/moa | |||
≤4 million | 77 (33.3) | 957 (29.7) | 0.240 |
>4 million | 154 (66.7) | 2,269 (70.3) | |
Smoking | |||
Never smoked | 195 (84.4) | 2,896 (89.8) | 0.016 |
Pre-pregnancy smoking | 25 (10.8) | 256 (7.9) | |
Smoking in early pregnancyb | 11 (4.8) | 74 (2.3) | |
Alcohol consumption | |||
Never drank | 46 (19.9) | 624 (19.3) | 0.832 |
Drinker | 185 (80.1) | 2,602 (80.7) | |
MDA index | 32.6±4.3 | 33.3±4.3 | 0.036 |
Hypertension | |||
No | 221 (95.7) | 3,191 (98.9) | <0.001 |
Yes | 10 (4.3) | 35 (1.1) | |
Polycystic ovary syndrome | |||
No | 224 (97.0) | 3,177 (98.5) | 0.079 |
Yes | 7 (3.0) | 49 (1.5) | |
First-degree family history of diabetes | |||
No | 147 (63.6) | 2,589 (80.3) | <0.001 |
Yes | 84 (36.4) | 637 (19.7) | |
Parity | |||
0 | 116 (50.2) | 1,940 (60.1) | <0.001 |
≥1 | 115 (49.8) | 1,286 (39.9) | |
Pre-existing GDM (parity ≥1) | |||
No | 99 (86.1)) | 1,246 (96.9) | <0.001 |
Yes | 16 (13.9) | 40 (3.1) | |
Previous macrosomia (parity ≥1) | |||
No | 100 (87.0) | 1,244 (96.7) | <0.001 |
Yes | 15 (13.0) | 42 (3.3) |
Values are presented as number (%) or average±standard deviation. P values were determined using Pearson chi-square tests or t-tests.
GDM, gestational diabetes mellitus; BMI, body mass index; MDA, mini dietary assessment.
a Reflecting the Korean household average monthly income in 2013,
b Continued to smoke from before pregnancy through study enrollment (early pregnancy).
Variable | GDM (n=231) | Normal (n=3,226) | P value |
---|---|---|---|
Pre-pregnancya | 226 | 3,116 | |
Walkingb | 82 (36.3) | 1,387 (44.5) | 0.016 |
MVPAc | 135 (59.7) | 1,891 (60.7) | 0.777 |
Muscle-strengthening activityd | 12 (5.3) | 363 (11.6) | 0.004 |
Both MVPA and muscle-strengthening activity | 11 (4.9) | 331 (10.6) | 0.006 |
1st trimestera | 228 | 3,132 | |
Walkingb | 48 (21.1) | 789 (25.2) | 0.163 |
MVPAc | 70 (30.7) | 1,060 (33.8) | 0.332 |
Muscle-strengthening activityd | 3 (1.3) | 27 (0.9) | 0.482 |
Both MVPA and muscle-strengthening activity | 2 (0.9) | 20 (0.6) | 0.666 |
2nd trimestera | 221 | 2,990 | |
Walkingb | 60 (27.1) | 949 (31.7) | 0.156 |
MVPAc | 97 (43.9) | 1,494 (50.0) | 0.081 |
Muscle-strengthening activityd | 0 | 36 (1.2) | 0.101 |
Both MVPA and muscle-strengthening activity | 0 | 15 (0.5) | 0.291 |
3rd trimestera | 203 | 2,761 | |
Walkingb | 70 (34.5) | 777 (28.1) | 0.054 |
MVPAc | 95 (46.8) | 1,275 (46.2) | 0.864 |
Muscle-strengthening activityd | 4 (2.0) | 47 (1.7) | 0.779 |
Both MVPA and muscle-strengthening activity | 4 (2.0) | 39 (1.4) | 0.521 |
Postpartuma | 166 | 2,288 | |
Walkingb | 10 (6.0) | 178 (7.8) | 0.412 |
MVPAc | 23 (13.9) | 340 (14.9) | 0.725 |
Muscle-strengthening activityd | 4 (2.4) | 52 (2.3) | 0.909 |
Both MVPA and muscle-strengthening activity | 4 (2.4) | 36 (1.6) | 0.411 |
Values are presented as number (%) of subjects who met each performance indicator of physical activity. P value was determined using the Pearson chi-square test.
GDM, gestational diabetes mellitus; MVPA, moderate to vigorous physical activity.
a Due to the nature of a longitudinal study, the number of respondents to the physical activity questionnaire varied at each time point,
b Walking performance: a minimum of 10 minutes in a single session and at least 30 minutes per day for a minimum of 5 days in the past week,
c MVPA performance: in moderate-intensity physical activity for 2 hours and 30 minutes, or high-intensity physical activity for 1 hour and 15 minutes per week, or a combination of moderate and high-intensity physical activity (1 minute of high-intensity equals 2 minutes of moderate-intensity) equivalent to the prescribed duration for each activity in a week,
d Muscle-strengthening activity performance: at least 2 days in the past week.
Pre-pregnancy period | GDM (n=226)a | Normal (n=3,116)a | Crude OR | 95% CI | P value | Adjusted ORe | 95% CI | P value |
---|---|---|---|---|---|---|---|---|
Walkingb | ||||||||
Met (n=1,469) | 82 (5.6) | 1,387 (94.4) | 0.73 | 0.55–0.96 | 0.026 | 0.82 | 0.61–1.10 | 0.183 |
Non-met (n=1,873) | 144 (7.7) | 1,729 (92.3) | 1 (ref) | 1 (ref) | ||||
MVPAc | ||||||||
Met (n=2,026) | 135 (6.7) | 1,891 (93.3) | 0.96 | 0.73–1.27 | 0.777 | 1.05 | 0.79–1.40 | 0.740 |
Non-met (n=1,316) | 91 (6.9) | 1,225 (93.1) | 1 (ref) | 1 (ref) | ||||
Muscle-strengthening activityd | ||||||||
Met (n=375) | 12 (3.2) | 363 (96.8) | 0.44 | 0.24–0.79 | 0.006 | 0.46 | 0.25–0.85 | 0.013 |
Non-met (n=2,967) | 214 (7.2) | 2,753 (92.8) | 1 (ref) | 1 (ref) | ||||
Both MVPA and muscle-strengthening activity | ||||||||
Met (n=342) | 11 (3.2) | 331 (96.8) | 0.43 | 0.23–0.80 | 0.007 | 0.46 | 0.25–0.87 | 0.016 |
Non-met (n=3,000) | 215 (7.2) | 2,785 (92.8) | 1 (ref) | 1 (ref) |
Values are presented as number (%).
GDM, gestational diabetes mellitus; OR, odd ratio; CI, confidence interval; MVPA, moderate to vigorous physical activity.
a In this longitudinal study, the pre-pregnancy sample included 3,342 respondents: 226 with GDM and 3,116 normal,
b Walking performance: a minimum of 10 minutes in a single session and at least 30 minutes per day for a minimum of 5 days in the past week,
c MVPA performance: in moderate-intensity physical activity for 2 hours and 30 minutes, or high-intensity physical activity for 1 hour and 15 minutes per week, or a combination of moderate and high-intensity physical activity (1 minute of high-intensity equals 2 minutes of moderate-intensity) equivalent to the prescribed duration for each activity in a week,
d Muscle-strengthening activity performance: at least 2 days in the past week,
e Binomial logistic regression analysis adjusted for maternal age, pre-pregnancy body mass index, educational status, smoking, mini dietary assessment index, hypertension, first-degree family history of diabetes mellitus, and pre-existing GDM.
Characteristic | GDM (n=231) | Normal (n=3,226) | P value |
---|---|---|---|
Maternal age, yr | |||
Maternal age <35 | 114 (49.4) | 2,078 (64.4) | <0.001 |
Maternal age ≥35 | 117 (50.6) | 1,148 (35.6) | |
Pre-pregnancy BMI, kg/m2 | |||
BMI <23 | 130 (563) | 2,609 (80.9) | <0.001 |
23≤ BMI <25 | 36 (15.6) | 325 (10.1) | |
BMI ≥25 | 65 (28.1) | 292 (9.1) | |
Educational status | |||
≤High school | 29 (12.6) | 255 (7.9) | 0.033 |
College | 169 (73.2) | 2,418 (75.0) | |
Graduate school | 33 (14.3) | 553 (17.1) | |
Household income, Korean won/mo |
|||
≤4 million | 77 (33.3) | 957 (29.7) | 0.240 |
>4 million | 154 (66.7) | 2,269 (70.3) | |
Smoking | |||
Never smoked | 195 (84.4) | 2,896 (89.8) | 0.016 |
Pre-pregnancy smoking | 25 (10.8) | 256 (7.9) | |
Smoking in early pregnancy |
11 (4.8) | 74 (2.3) | |
Alcohol consumption | |||
Never drank | 46 (19.9) | 624 (19.3) | 0.832 |
Drinker | 185 (80.1) | 2,602 (80.7) | |
MDA index | 32.6±4.3 | 33.3±4.3 | 0.036 |
Hypertension | |||
No | 221 (95.7) | 3,191 (98.9) | <0.001 |
Yes | 10 (4.3) | 35 (1.1) | |
Polycystic ovary syndrome | |||
No | 224 (97.0) | 3,177 (98.5) | 0.079 |
Yes | 7 (3.0) | 49 (1.5) | |
First-degree family history of diabetes | |||
No | 147 (63.6) | 2,589 (80.3) | <0.001 |
Yes | 84 (36.4) | 637 (19.7) | |
Parity | |||
0 | 116 (50.2) | 1,940 (60.1) | <0.001 |
≥1 | 115 (49.8) | 1,286 (39.9) | |
Pre-existing GDM (parity ≥1) | |||
No | 99 (86.1)) | 1,246 (96.9) | <0.001 |
Yes | 16 (13.9) | 40 (3.1) | |
Previous macrosomia (parity ≥1) | |||
No | 100 (87.0) | 1,244 (96.7) | <0.001 |
Yes | 15 (13.0) | 42 (3.3) |
Variable | GDM (n=231) | Normal (n=3,226) | P value |
---|---|---|---|
Pre-pregnancy |
226 | 3,116 | |
Walking |
82 (36.3) | 1,387 (44.5) | 0.016 |
MVPA |
135 (59.7) | 1,891 (60.7) | 0.777 |
Muscle-strengthening activity |
12 (5.3) | 363 (11.6) | 0.004 |
Both MVPA and muscle-strengthening activity | 11 (4.9) | 331 (10.6) | 0.006 |
1st trimester |
228 | 3,132 | |
Walking |
48 (21.1) | 789 (25.2) | 0.163 |
MVPA |
70 (30.7) | 1,060 (33.8) | 0.332 |
Muscle-strengthening activity |
3 (1.3) | 27 (0.9) | 0.482 |
Both MVPA and muscle-strengthening activity | 2 (0.9) | 20 (0.6) | 0.666 |
2nd trimester |
221 | 2,990 | |
Walking |
60 (27.1) | 949 (31.7) | 0.156 |
MVPA |
97 (43.9) | 1,494 (50.0) | 0.081 |
Muscle-strengthening activity |
0 | 36 (1.2) | 0.101 |
Both MVPA and muscle-strengthening activity | 0 | 15 (0.5) | 0.291 |
3rd trimester |
203 | 2,761 | |
Walking |
70 (34.5) | 777 (28.1) | 0.054 |
MVPA |
95 (46.8) | 1,275 (46.2) | 0.864 |
Muscle-strengthening activity |
4 (2.0) | 47 (1.7) | 0.779 |
Both MVPA and muscle-strengthening activity | 4 (2.0) | 39 (1.4) | 0.521 |
Postpartum |
166 | 2,288 | |
Walking |
10 (6.0) | 178 (7.8) | 0.412 |
MVPA |
23 (13.9) | 340 (14.9) | 0.725 |
Muscle-strengthening activity |
4 (2.4) | 52 (2.3) | 0.909 |
Both MVPA and muscle-strengthening activity | 4 (2.4) | 36 (1.6) | 0.411 |
Pre-pregnancy period | GDM (n=226) |
Normal (n=3,116) |
Crude OR | 95% CI | P value | Adjusted OR |
95% CI | P value |
---|---|---|---|---|---|---|---|---|
Walking |
||||||||
Met (n=1,469) | 82 (5.6) | 1,387 (94.4) | 0.73 | 0.55–0.96 | 0.026 | 0.82 | 0.61–1.10 | 0.183 |
Non-met (n=1,873) | 144 (7.7) | 1,729 (92.3) | 1 (ref) | 1 (ref) | ||||
MVPA |
||||||||
Met (n=2,026) | 135 (6.7) | 1,891 (93.3) | 0.96 | 0.73–1.27 | 0.777 | 1.05 | 0.79–1.40 | 0.740 |
Non-met (n=1,316) | 91 (6.9) | 1,225 (93.1) | 1 (ref) | 1 (ref) | ||||
Muscle-strengthening activity |
||||||||
Met (n=375) | 12 (3.2) | 363 (96.8) | 0.44 | 0.24–0.79 | 0.006 | 0.46 | 0.25–0.85 | 0.013 |
Non-met (n=2,967) | 214 (7.2) | 2,753 (92.8) | 1 (ref) | 1 (ref) | ||||
Both MVPA and muscle-strengthening activity | ||||||||
Met (n=342) | 11 (3.2) | 331 (96.8) | 0.43 | 0.23–0.80 | 0.007 | 0.46 | 0.25–0.87 | 0.016 |
Non-met (n=3,000) | 215 (7.2) | 2,785 (92.8) | 1 (ref) | 1 (ref) |
Values are presented as number (%) or average±standard deviation. GDM, gestational diabetes mellitus; BMI, body mass index; MDA, mini dietary assessment. Reflecting the Korean household average monthly income in 2013, Continued to smoke from before pregnancy through study enrollment (early pregnancy).
Values are presented as number (%) of subjects who met each performance indicator of physical activity. GDM, gestational diabetes mellitus; MVPA, moderate to vigorous physical activity. Due to the nature of a longitudinal study, the number of respondents to the physical activity questionnaire varied at each time point, Walking performance: a minimum of 10 minutes in a single session and at least 30 minutes per day for a minimum of 5 days in the past week, MVPA performance: in moderate-intensity physical activity for 2 hours and 30 minutes, or high-intensity physical activity for 1 hour and 15 minutes per week, or a combination of moderate and high-intensity physical activity (1 minute of high-intensity equals 2 minutes of moderate-intensity) equivalent to the prescribed duration for each activity in a week, Muscle-strengthening activity performance: at least 2 days in the past week.
Values are presented as number (%). GDM, gestational diabetes mellitus; OR, odd ratio; CI, confidence interval; MVPA, moderate to vigorous physical activity. In this longitudinal study, the pre-pregnancy sample included 3,342 respondents: 226 with GDM and 3,116 normal, Walking performance: a minimum of 10 minutes in a single session and at least 30 minutes per day for a minimum of 5 days in the past week, MVPA performance: in moderate-intensity physical activity for 2 hours and 30 minutes, or high-intensity physical activity for 1 hour and 15 minutes per week, or a combination of moderate and high-intensity physical activity (1 minute of high-intensity equals 2 minutes of moderate-intensity) equivalent to the prescribed duration for each activity in a week, Muscle-strengthening activity performance: at least 2 days in the past week, Binomial logistic regression analysis adjusted for maternal age, pre-pregnancy body mass index, educational status, smoking, mini dietary assessment index, hypertension, first-degree family history of diabetes mellitus, and pre-existing GDM.